Informações:
Falhas:
ID
30576
Descrição
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00490646
Link
https://clinicaltrials.gov/show/NCT00490646
Palavras-chave
Versões (1)
- 16/06/2018 16/06/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
16 de junho de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Metastatic Breast Cancer NCT00490646
Eligibility Metastatic Breast Cancer NCT00490646
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Breast Cancer NCT00490646
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Locally advanced breast cancer | Secondary malignant neoplasm of female breast HER2 Positive | Chemotherapy Absent | Trastuzumab Absent
Item
locally advanced or metastatic her2+ breast cancer not previously treated with chemotherapy or trastuzumab.
boolean
C3495949 (UMLS CUI [1])
C0346993 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0728747 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0346993 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0728747 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Chemotherapy, Adjuvant | Chemotherapy Neoadjuvant | Trastuzumab Adjuvant | Trastuzumab Neoadjuvant | Exception Recurrent disease Post Taxane | Exception Recurrent disease Post Trastuzumab
Item
subjects who had received prior (neo)adjuvant chemotherapy or trastuzumab were eligible except if they relapsed within 12 months after the last dose of a taxane or trastuzumab given as (neo)adjuvant therapy.
boolean
C0085533 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C0728747 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0277556 (UMLS CUI [5,2])
C0687676 (UMLS CUI [5,3])
C0215136 (UMLS CUI [5,4])
C1705847 (UMLS CUI [6,1])
C0277556 (UMLS CUI [6,2])
C0687676 (UMLS CUI [6,3])
C0728747 (UMLS CUI [6,4])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C0728747 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0277556 (UMLS CUI [5,2])
C0687676 (UMLS CUI [5,3])
C0215136 (UMLS CUI [5,4])
C1705847 (UMLS CUI [6,1])
C0277556 (UMLS CUI [6,2])
C0687676 (UMLS CUI [6,3])
C0728747 (UMLS CUI [6,4])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) ≥50%
boolean
C0428772 (UMLS CUI [1])
Chemotherapy Secondary malignant neoplasm of female breast | Trastuzumab Secondary malignant neoplasm of female breast
Item
prior chemotherapy or trastuzumab for metastatic breast cancer (mbc)
boolean
C0392920 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
C0728747 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
C0346993 (UMLS CUI [1,2])
C0728747 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
Recurrent disease | Status post Taxane Adjuvant | Status post Taxane Neoadjuvant | Status post Trastuzumab Adjuvant | Status post Trastuzumab Neoadjuvant
Item
relapse within 1 year after (neo)adjuvant taxane or trastuzumab
boolean
C0277556 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0215136 (UMLS CUI [2,2])
C1522673 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0215136 (UMLS CUI [3,2])
C0600558 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C0728747 (UMLS CUI [4,2])
C1522673 (UMLS CUI [4,3])
C0231290 (UMLS CUI [5,1])
C0728747 (UMLS CUI [5,2])
C0600558 (UMLS CUI [5,3])
C0231290 (UMLS CUI [2,1])
C0215136 (UMLS CUI [2,2])
C1522673 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0215136 (UMLS CUI [3,2])
C0600558 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C0728747 (UMLS CUI [4,2])
C1522673 (UMLS CUI [4,3])
C0231290 (UMLS CUI [5,1])
C0728747 (UMLS CUI [5,2])
C0600558 (UMLS CUI [5,3])
Neuropathy CTCAE Grades
Item
neuropathy > grade 1
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
Cardiovascular Diseases
Item
significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
any brain metastases
boolean
C0220650 (UMLS CUI [1])